# Commission Regulation (EC) No 478/2009 of 8 June 2009 amending Annexes I and III to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, as regards monepantel (Text with EEA relevance), Division (1): A new point 2.1.8 ‘Others’ which includes the new substance ‘Monepantel’ is added to Annex I (List of pharmacologically active substances for which maximum residue limits have been fixed), as follows:

Extent: E+W+S+N.I.

2.
Antiparasitic agents
2.1.
Agents acting against endoparasites
‘2.1.8.
Others
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Other provisions
Monepantel
Monepantel-sulfone
Ovine
700 μg/kg
Muscle
Not for use in animals producing milk for human consumption’
7 000 μg/kg
Fat
5 000 μg/kg
Liver
2 000 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/2009/478/annex/division/1 (the official version)
Page: https://openlegislation.uk/eu-regulation-2009-478/annex/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

